Yoshio Ohno

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
Clinical Value of a Novel Apparent Diffusion Coefficient-Based Bi-Color Map for Detecting Clinically Significant Prostate Cancer: A Retrospective Study.

|Aug 28, 2025
Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma.

Yosuke Hirasawa, Atsushi Satomura, Mitsuo Okada

|Aug 20, 2025
Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study.

Takuhisa Nukaya, Kiyoshi Takahara, Shingo Toyoda

|Aug 14, 2025
Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer.

Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto

|Dec 19, 2023
Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.

Wataru Fukuokaya, Yuhei Koike, Yuji Yata

Pageof 1

Frequent Collaborators

4 joint publications

Yosuke Hirasawa

3 joint publications

Wataru Fukuokaya

3 joint publications

Kiyoshi Takahara

2 joint publications

Takahiro Kimura